Clinical trial
Blood Alpha-Synuclein, Gene Expression, and Smell Testing as Diagnostic and Prognostic Biomarkers in Parkinson's Disease
NCT00653783 is registered in ClinicalTrials.gov with The Parkinson Study Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Blood Alpha-Synuclein, Gene Expression, and Smell Testing as Diagnostic and Prognostic Biomarkers in Parkinson's Disease
- Lead sponsor
- The Parkinson Study Group
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- August 31, 2007
- Completion date
- Not reported
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
multiple system atrophy, parkinson disease, progressive supranuclear palsy